22 results
8-K
EX-10.2
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
that (a) relate to the business of the Company or its subsidiaries or other affiliates or any customer of, supplier to or business partner of the Company
DEF 14A
BDTX
Black Diamond Therapeutics Inc
27 Apr 21
Definitive proxy
4:06pm
concern anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier or other interested party
10-Q
ttixzlq6 w5dp6pq0
12 May 20
Quarterly report
7:34am
10-K
wca72t9 thfa52ka2lz
24 Mar 20
Annual report
7:47am
424B4
1xjtnu3pvws08vke7
30 Jan 20
Prospectus supplement with pricing info
4:43pm
S-1/A
EX-1.1
m9egb
21 Jan 20
IPO registration (amended)
8:24am
S-1/A
wxbb4vs4udo k28
21 Jan 20
IPO registration (amended)
8:24am
S-1
dasnpgbux1
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.7
wmbm rcju
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.10
3y9gg1rmn 64hgr9fa9
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.8
2hcwryvn7agrgwc
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.9
pm2r7rt7p pxuqs
3 Jan 20
IPO registration
3:23pm
DRS/A
n1wbaiwde
13 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
jzab8zgb
30 Oct 19
Draft registration statement (amended)
12:00am